Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Dec;44(12):4573-4574.
doi: 10.1007/s10072-023-06993-5. Epub 2023 Aug 3.

Eculizumab as a promising rescue therapy for acute exacerbations of myasthenia gravis

Sohyeon Kim  1 , Jae-Joon Lee  1 , Hung Youl Seok  2
Affiliations
Comment

Eculizumab as a promising rescue therapy for acute exacerbations of myasthenia gravis

Sohyeon Kim et al. Neurol Sci. 2023 Dec.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Vinciguerra C, Bevilacqua L, Toriello A, Iovino A, Piscosquito G, Calicchio G, Barone P (2023) Starting eculizumab as rescue therapy in refractory myasthenic crisis. Neurol Sci. https://doi.org/10.1007/s10072-023-06900-y
    1. Grob D, Brunner N, Namba T, Pagala M (2008) Lifetime course of myasthenia gravis. Muscle Nerve 37(2):141–149. https://doi.org/10.1002/mus.20950 - DOI - PubMed
    1. Di Stefano V, Lupica A, Rispoli MG, Di Muzio A, Brighina F, Rodolico C (2020) Rituximab in AChR subtype of myasthenia gravis: systematic review. J Neurol Neurosurg Psychiatry 91(4):392–395. https://doi.org/10.1136/jnnp-2019-322606 - DOI - PubMed
    1. Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT et al (2017) Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol 16(12):976–986. https://doi.org/10.1016/S1474-4422(17)30369-1 - DOI - PubMed
    1. Narayanaswami P, Sanders DB, Wolfe G, Benatar M, Cea G, Evoli A, Gilhus NE, Illa I, Kuntz NL, Massey J et al (2021) International consensus guidance for management of myasthenia gravis: 2020 update. Neurology 96(3):114–122. https://doi.org/10.1212/WNL.0000000000011124 - DOI - PubMed - PMC

MeSH terms

Substances

LinkOut - more resources